{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:17:57Z","timestamp":1780975077872,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"crossref","award":["702555"],"award-info":[{"award-number":["702555"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"crossref","award":["IT02931"],"award-info":[{"award-number":["IT02931"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","award":["312809-11"],"award-info":[{"award-number":["312809-11"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jbo.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T07:30:33Z","timestamp":1484292633000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration"],"prefix":"10.1016","volume":"6","author":[{"given":"Anas","family":"Nooh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek H.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Tabari\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake E.","family":"Barralet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2017.01.001_bib1","first-page":"31","article-title":"Why do some cancers preferentially metastasize to bone?","volume":"14","author":"Clezardin","year":"2012","journal-title":"Oncologie"},{"key":"10.1016\/j.jbo.2017.01.001_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrclinonc.2010.17","article-title":"Treatment of painful bone metastases","volume":"7","author":"Rades","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbo.2017.01.001_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/CCO.0000000000000071","article-title":"Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer","volume":"26","author":"Yong","year":"2014","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jbo.2017.01.001_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2017.01.001_bib5","doi-asserted-by":"crossref","unstructured":"R.G. Russell , N.B. Watts, F.H. Ebetino, M.J. Rogers, Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy, Osteoporosis international: A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008, 19, pp. 733\u201359.","DOI":"10.1007\/s00198-007-0540-8"},{"issue":"Suppl 1","key":"10.1016\/j.jbo.2017.01.001_bib6","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ctrv.2008.03.008","article-title":"Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone","volume":"34","author":"Lipton","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jbo.2017.01.001_bib7","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2017.01.001_bib8","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","article-title":"Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial","volume":"23","author":"Kohno","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2017.01.001_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2106\/JBJS.I.00518","article-title":"Locally delivered bisphosphonate for enhancement of bone formation and implant fixation","volume":"91","author":"Bobyn","year":"2009","journal-title":"J. Bone Jt. Surg."},{"key":"10.1016\/j.jbo.2017.01.001_bib10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"1-0.5","key":"10.1016\/j.jbo.2017.01.001_bib11","first-page":"27","article-title":"Preclinical mouse models of human prostate cancer and their utility in drug discovery","volume":"14.5","author":"Park","year":"2010","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.jbo.2017.01.001_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jnci\/djk054","article-title":"Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis","volume":"99","author":"Daubine","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbo.2017.01.001_bib13","doi-asserted-by":"crossref","first-page":"e12093","DOI":"10.1371\/journal.pone.0012093","article-title":"ADAM10 releases a soluble form of the GPNMB\/Osteoactivin extracellular domain with angiogenic properties","volume":"5","author":"Rose","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2017.01.001_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00004728-199411000-00016","article-title":"Injection of alcohol into bone metastases under CT guidance","volume":"18","author":"Gangi","year":"1994","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.jbo.2017.01.001_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1302\/0301-620X.71B5.2584251","article-title":"Methotrexate diffusion from acrylic cement. Local chemotherapy for bone tumours","volume":"71","author":"Hernigou","year":"1989","journal-title":"J. Bone Jt. Surg. Br. Vol."},{"key":"10.1016\/j.jbo.2017.01.001_bib16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/00007632-200107150-00015","article-title":"Efficacy and safety of ethanol injections in 18 cases of vertebral hemangioma: a mean follow-up of 2 years","volume":"26","author":"Bas","year":"2001","journal-title":"Spine"},{"key":"10.1016\/j.jbo.2017.01.001_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1148\/radiographics.19.3.g99ma04647","article-title":"Therapeutic percutaneous injections in the treatment of malignant acetabular osteolyses","volume":"19","author":"Cotten","year":"1999","journal-title":"Radiogr.: a Rev. Publ. Radiol. Soc. North Am. Inc."},{"issue":"143","key":"10.1016\/j.jbo.2017.01.001_bib18","first-page":"312","article-title":"[Microinvasive CT-controlled tumor therapy of soft tissue and skeletal metastases]","volume":"1993","author":"Gronemeyer","year":"1946","journal-title":"Wien. Med. Wochenschr."},{"issue":"Suppl 6","key":"10.1016\/j.jbo.2017.01.001_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2106\/JBJS.I.00518","article-title":"Locally delivered bisphosphonate for enhancement of bone formation and implant fixation","volume":"91","author":"Bobyn","year":"2009","journal-title":"J. Bone Jt. Surg. Am."},{"key":"10.1016\/j.jbo.2017.01.001_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00776-009-1352-9","article-title":"Effect of locally administered zoledronic acid on injury-induced intramembranous bone regeneration and osseointegration of a titanium implant in rats","volume":"14","author":"Miettinen","year":"2009","journal-title":"J. Orthop. Sci.: Off. J. Jpn. Orthop. Assoc."},{"key":"10.1016\/j.jbo.2017.01.001_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/ten.teb.2011.0737","article-title":"Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants","volume":"18","author":"Cattalini","year":"2012","journal-title":"Tissue Eng. Part B: Rev."},{"key":"10.1016\/j.jbo.2017.01.001_bib22","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1016\/j.actbio.2014.07.012","article-title":"Vertebroplasty using bisphosphonate-loaded calcium phosphate cement in a standardized vertebral body bone defect in an osteoporotic sheep model","volume":"10","author":"Verron","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jbo.2017.01.001_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bone.2008.10.047","article-title":"Inhibition of bone resorption and growth of breast cancer in the bone microenvironment","volume":"44","author":"Buijs","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2017.01.001_bib24","doi-asserted-by":"crossref","DOI":"10.3791\/4260","article-title":"Models of bone metastasis","author":"Campbell","year":"2012","journal-title":"JoVE J. Vis. Exp."},{"key":"10.1016\/j.jbo.2017.01.001_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2013.07.024","article-title":"Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models","volume":"339","author":"Luo","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbo.2017.01.001_bib26","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1359\/jbmr.2001.16.11.2027","article-title":"Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions","volume":"16","author":"Peyruchaud","year":"2001","journal-title":"J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2017.01.001_bib27","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1158\/1078-0432.CCR-08-1616","article-title":"Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model","volume":"15","author":"Labrinidis","year":"2009","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jbo.2017.01.001_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2007.07.007","article-title":"Bisphosphonates in cancer therapy","volume":"257","author":"Stresing","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbo.2017.01.001_bib29","doi-asserted-by":"crossref","first-page":"e79101","DOI":"10.1371\/journal.pone.0079101","article-title":"Combination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft model","volume":"8","author":"Previdi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbo.2017.01.001_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1593\/neo.10282","article-title":"How do bisphosphonates inhibit bone metastasis in vivo?","volume":"12","author":"Fournier","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbo.2017.01.001_bib31","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1158\/0008-5472.CAN-04-4188","article-title":"Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo","volume":"65","author":"van der Pluijm","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2017.01.001_bib32","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1158\/0008-5472.CAN-08-2195","article-title":"Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo","volume":"68","author":"Fournier","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbo.2017.01.001_bib33","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jbo.2017.01.001_bib34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbo.2017.01.001_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0009922812452118","article-title":"Bisphosphonates use in children","volume":"51","author":"Sebestyen","year":"2012","journal-title":"Clin. Pediatr."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137416301038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137416301038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:16:30Z","timestamp":1761941790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137416301038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":35,"alternative-id":["S2212137416301038"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2017.01.001","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}